Related Experiment Video
Updated: Aug 19, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Canine and feline blood donor screening for infectious disease
K Jane Wardrop1, Nyssa Reine, Adam Birkenheuer
1College of Veterinary Medicine, Washington State University, Pullman, WA, USA. kjw@vetmed.wsu.edu
Insights
Screening blood donors for infectious diseases is crucial to minimize disease transmission risks in canine and feline blood transfusions. Careful consideration of disease prevalence and donor health ensures safer blood products for pets.
Area of Science:
- Veterinary Medicine
- Comparative Pathology
- Transfusion Medicine
Background:
- Growing demand for blood products in veterinary medicine necessitates enhanced safety protocols.
- Blood transfusions in animals carry inherent risks, including the transmission of infectious diseases.
- Current screening practices require optimization to address emerging threats and ensure transfusion safety.
Framework:
- Developing comprehensive donor screening programs considering geographic disease prevalence.
- Evaluating breed-specific disease predilections to tailor screening protocols.
- Establishing clear guidelines for documenting transfusion-transmitted diseases.
Implementation:
- Implementing rigorous health care and management practices for blood donors.
- Utilizing advanced diagnostic tools for detecting bloodborne pathogens in donor animals.
- Standardizing donor selection criteria to minimize transfusion risks.
Implications:
- Improved safety and efficacy of blood transfusions in veterinary practice.
- Reduced incidence of transfusion-transmitted infections in companion animals.
- Enhanced overall animal health and welfare through safer medical interventions.
Abstract:
Thousands of blood transfusions are performed each year on dogs and cats, and the demand for blood products continues to grow. Risks associated with transfusions include the risk of disease transmission. Appropriate screening of blood donors for bloodborne infectious disease agents should be performed to lessen this risk. Geographic restrictions of disease, breed predilection, and documentation of actual disease transmission by transfusion all are factors that might need to be considered when making a decision on what screening program to use. In addition, factors involving general health care and management of blood donors should be employed to further ensure blood safety.

